Что означает «Очистить»?
Животное не является носителем мутации. Болезнь не разовьется и не передаст.
The DNA test for Primary Ciliary Dyskinesia (PCD) in Alaskan Malamutes is essential for responsible breeders and dog owners. PCD is a genetic disorder that affects the cilia function, leading to respiratory issues and reduced quality of life in affected dogs. Early detection through this DNA test helps identify carriers and affected Alaskan Malamutes, enabling informed breeding decisions to reduce the incidence of PCD. By using the PCD DNA test, breeders can promote healthier bloodlines and improve overall breed health. This test is simple, accurate, and vital for preventing the spread of this hereditary condition. Ensure your Alaskan Malamute’s well-being by opting for the PCD DNA test today. Protect your dog’s future with reliable genetic screening.
Primary Ciliary Dyskinesia (PCD) is a genetic disorder affecting the cilia function in Alaskan Malamutes, leading to respiratory issues and reduced quality of life. A DNA test for PCD helps identify carriers and affected dogs, enabling responsible breeding decisions. Early detection through testing can prevent the spread of this condition within the breed. This test is crucial for maintaining the health and longevity of Alaskan Malamutes. Responsible breeders use DNA testing to promote healthier generations of dogs.
Этот ДНК-тест входит в комплект поставки, начиная с нашего пакета. Basic — а также входит в состав пакетов Basic, Standard, Advanced, Complete.
Посмотреть пакеты тестов ДНК →Primary Ciliary Dyskinesia (PCD) is a genetic disorder that affects the cilia, which are tiny hair-like structures that line the respiratory tract, making them crucial for clearing mucus and debris from the airways. This condition can lead to a variety of respiratory issues and chronic infections, significantly impacting the health and quality of life of affected dogs.
PCD is caused by mutations in genes that are essential for the proper functioning of cilia. In Alaskan Malamutes, specific genetic markers have been identified that are associated with this condition. Understanding the genetic basis of PCD helps in developing targeted management strategies and breeding programs aimed at reducing the prevalence of the disorder within the breed.
Dogs with PCD often exhibit a range of clinical signs, which can include chronic coughing, nasal discharge, and recurrent respiratory infections. These symptoms can manifest as early as puppyhood and may worsen over time if not properly managed. It is important for dog owners to recognize these signs and seek veterinary advice early on to ensure appropriate care and intervention.
Diagnosis of Primary Ciliary Dyskinesia typically involves a combination of clinical evaluation, imaging studies, and genetic testing. The DNA test specifically designed for Alaskan Malamutes can identify the presence of mutations associated with PCD, providing clarity for breeders and owners regarding the risk of the condition in their dogs.
While there is no cure for PCD, effective management strategies can help improve the quality of life for affected dogs. These may include regular veterinary check-ups, medication to manage infections, and supportive care such as nebulization therapy to help clear mucus from the airways. Additionally, owners should be proactive in monitoring their dog's respiratory health and maintaining a clean living environment to reduce exposure to respiratory irritants.
DNA testing for Primary Ciliary Dyskinesia is an essential tool for responsible breeding practices. By identifying carriers of the genetic mutations associated with PCD, breeders can make informed decisions to minimize the risk of passing the condition to future generations. This proactive approach is vital for maintaining the health and well-being of Alaskan Malamutes as a breed.
Животное не является носителем мутации. Болезнь не разовьется и не передаст.
Нет. В целом животное здорово, но может передать мутацию своему организму. потомство.
Он несет в себе две мутировавшие копии. Клинические признаки ожидаются в зависимости от болезнь. Его не следует разводить.
Некоторые заболевания связаны с полом, поэтому их выраженность варьируется в зависимости от пол животного.
This DNA test detects the mutation associated with Primary Ciliary Dyskinesia In Alaskan Malamute (PCD-AM) in order to identify clear, carrier, or at-risk animals.
Тестирование ДНК помогает заводчикам планировать более безопасные спаривания и снизить риск передачи мутации потомству.
Тип наследования, указанный для этого теста, — аутосомно-рецессивный.
This test analyses the mutation NME5 c.43delA.
Не обязательно. Интерпретация зависит от характера наследования и полученного генотипа.
Anderegg Linda, Im Hof Gut Michelle, Hetzel Udo, Howerth Elizabeth W, Leuthard Fabienne, Kyöstilä Kaisa, Lohi Hannes, Pettitt Louise, Mellersh Cathryn, Minor Katie M, Mickelson James R, Batcher Kevin, Bannasch Danika, Jagannathan Vidhya, Leeb Tosso. NME5 frameshift variant in Alaskan Malamutes with primary ciliary dyskinesia. PLoS Genet. 2019 Sep 3;15(9):e1008378. doi: 10.1371/journal.pgen.1008378. eCollection 2019 Sep.
Ваша конфиденциальность, ваш выбор
Мы используем необходимые файлы cookie для работы веб-сайта. Дополнительные файлы cookie (например, поставщиков встроенного контента) отключены по умолчанию и включаются только с вашего согласия. Вы можете изменить свой выбор в любое время, используя кнопку «Файлы cookie».
Требуется для основных функций и безопасности. Всегда включен.
Улучшает такие функции, как сохранение настроек или встраивание без рекламы.
Помогает нам понять использование сайта. По умолчанию отключено.
Реклама/отслеживание на сайтах (встраиваются некоторые видео/карты). По умолчанию отключено.